BioBM Revenue and Competitors
Estimated Revenue & Valuation
- BioBM's estimated annual revenue is currently $1.1M per year.
- BioBM's estimated revenue per employee is $155,000
Employee Data
- BioBM has 7 Employees.
- BioBM grew their employee count by 40% last year.
BioBM's People
Name | Title | Email/Phone |
---|
BioBM Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.4M | 35 | 0% | N/A | N/A |
#2 | $1.2M | 16 | -6% | N/A | N/A |
#3 | $13.6M | 88 | 4% | N/A | N/A |
#4 | $1.1M | 7 | 40% | N/A | N/A |
#5 | $0.9M | 11 | 10% | N/A | N/A |
#6 | $5.1M | 33 | 3% | N/A | N/A |
#7 | $132.5M | 855 | 6% | N/A | N/A |
#8 | $0.9M | 6 | 0% | N/A | N/A |
#9 | $0.6M | 4 | -20% | N/A | N/A |
#10 | $2.5M | 16 | 7% | N/A | N/A |
What Is BioBM?
Once upon a time, a great product could stand on its own. If you built it, they would find you. Unfortunately for many companies, that time is long gone. Scientists are facing more demands for their attention than ever, and a great company needs a great voice to help it rise above the crowd. BioBM provides that voice. BioBM is a full-service marketing agency and consultancy working with innovative, growth-oriented life science companies to forge commercial success. By taking a holistic approach to marketing, we can help any company become a leader through demand-generating and brand-building marketing. If you’re not afraid to do things differently, we’ll provide you with the next generation of marketing strategies, which will not only elevate your products and services, but turn your marketing program into a strategic advantage.
keywords:N/AN/A
Total Funding
7
Number of Employees
$1.1M
Revenue (est)
40%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.4M | 7 | N/A | N/A |
#2 | $0.7M | 7 | -22% | N/A |
#3 | $0.5M | 7 | 0% | N/A |
#4 | $0.9M | 7 | 17% | N/A |
#5 | $0.5M | 7 | -12% | N/A |